[go: up one dir, main page]

ES2105684T3 - Derivados insaturados de fosfonato de purinas y pirimidinas. - Google Patents

Derivados insaturados de fosfonato de purinas y pirimidinas.

Info

Publication number
ES2105684T3
ES2105684T3 ES94912742T ES94912742T ES2105684T3 ES 2105684 T3 ES2105684 T3 ES 2105684T3 ES 94912742 T ES94912742 T ES 94912742T ES 94912742 T ES94912742 T ES 94912742T ES 2105684 T3 ES2105684 T3 ES 2105684T3
Authority
ES
Spain
Prior art keywords
phosphonate
purine
pirimidine
unsaturated derivatives
antiviral agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94912742T
Other languages
English (en)
Inventor
Patrick Casara
Jean-Francoise Nave
Serge Halazy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2105684T3 publication Critical patent/ES2105684T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE EXPONEN DERIVADOS DE FOSFONATO INSATURADO NOVEDOSOS DE CIERTAS PURINAS O PIRIMIDINAS UTILES COMO AGENTES ANTIVIRALES; METODOS UTILES PARA SU PREPARACION Y EL USO DE ESTOS COMPUESTOS COMO AGENTES ANTIVIRALES EFICACES CONTRA LOS VIRUS DEL DNA, RETROVIRUS, Y LOS VIRUS INVOLUCRADOS EN LA FORMACION DE TUMORES.
ES94912742T 1993-04-01 1994-02-25 Derivados insaturados de fosfonato de purinas y pirimidinas. Expired - Lifetime ES2105684T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93400842A EP0618214A1 (en) 1993-04-01 1993-04-01 Unsaturated phosphonate derivatives of purines and pyrimidines

Publications (1)

Publication Number Publication Date
ES2105684T3 true ES2105684T3 (es) 1997-10-16

Family

ID=8214695

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94912742T Expired - Lifetime ES2105684T3 (es) 1993-04-01 1994-02-25 Derivados insaturados de fosfonato de purinas y pirimidinas.

Country Status (17)

Country Link
EP (2) EP0618214A1 (es)
JP (1) JPH08508481A (es)
CN (2) CN1046288C (es)
AT (1) ATE154605T1 (es)
AU (1) AU681395B2 (es)
CA (1) CA2159451C (es)
DE (1) DE69403910T2 (es)
DK (1) DK0701562T3 (es)
ES (1) ES2105684T3 (es)
FI (1) FI113539B (es)
GR (1) GR3024788T3 (es)
HU (1) HUT72459A (es)
IL (1) IL109152A0 (es)
NO (1) NO953878L (es)
NZ (1) NZ263904A (es)
WO (1) WO1994022882A1 (es)
ZA (1) ZA942092B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977061A (en) * 1995-04-21 1999-11-02 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic N6 - substituted nucleotide analagues and their use
TW369536B (en) * 1996-01-18 1999-09-11 Mitsubishi Chem Corp Phosphonate nucleotide compounds
FR2781229B1 (fr) * 1998-07-17 2001-11-30 Univ Nice Sophia Antipolis Nouveaux composes analogues des nucleotides, leurs procedes de preparation et leurs applications
GB9821058D0 (en) 1998-09-28 1998-11-18 Univ Cardiff Chemical compound
MXPA04000138A (es) 2001-06-29 2005-06-06 Acad Of Science Czech Republic Compuestos novedosos y metodos de trabajo.
JP2005508924A (ja) * 2001-08-30 2005-04-07 三菱ウェルファーマ株式会社 抗ウイルス剤
SI1644389T1 (sl) 2003-06-16 2011-06-30 Acad Of Science Czech Republic Pirimidinske spojine s fosfonatnimi skupinami kot antivirusni nukleotidni analogi
EP1656387A2 (en) * 2003-07-30 2006-05-17 Gilead Sciences, Inc. Nucleobase phosphonate analogs for antiviral treatment
EP1866319B1 (en) * 2005-04-01 2011-11-23 The Regents of The University of California Phosphono-pent-2-en-1-yl nucleosides and analogs
EP1879657A2 (en) * 2005-04-25 2008-01-23 Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic Use of compounds to enhance processivity of telomerase
CN100352823C (zh) * 2005-08-19 2007-12-05 浙江车头制药有限公司 一种腺嘌呤衍生物的制备方法
US8324179B2 (en) 2007-02-09 2012-12-04 Gilead Sciences, Inc. Nucleoside analogs for antiviral treatment
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
US9593137B2 (en) 2011-12-22 2017-03-14 Geron Corporation Guanine analogs as telomerase substrates and telomere length affectors
LT3416654T (lt) 2016-02-18 2022-01-10 Invirsa, Inc. 5’-adenozindifosfato ribozės (adpr) medicininis panaudojimas
ES2949441T3 (es) 2018-03-27 2023-09-28 Invirsa Inc Métodos para el uso de 5'-adenosina difosfato ribosa (ADPR)
CN108383872B (zh) * 2018-04-18 2019-07-12 南京师范大学 一种-1,1-二氟-3-磺酰基-2,4-戊二烯膦酸酯类化合物及其合成方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2017054C (en) * 1990-05-16 1999-08-10 Jack S. Wilson Automatic storage and retrieval system
WO1992001698A1 (en) * 1990-07-19 1992-02-06 Beecham Group Plc Antiviral phosphono-alken derivatives of purines
EP0531597A1 (en) * 1991-09-12 1993-03-17 Merrell Dow Pharmaceuticals Inc. Novel unsaturated acyclic phosphonate derivatives of purine and pyrimidine
DE69218968T2 (de) * 1991-10-11 1997-10-09 Inst Of Organic Chemistry And Antivirale acyclische phosphonomethoxyalkyl substituierte, alkenyl und alkynyl purin und pyrimidin-derivate

Also Published As

Publication number Publication date
AU681395B2 (en) 1997-08-28
FI954615A0 (fi) 1995-09-28
AU6516294A (en) 1994-10-24
WO1994022882A1 (en) 1994-10-13
HUT72459A (en) 1996-04-29
CA2159451C (en) 1999-04-13
EP0701562A1 (en) 1996-03-20
EP0618214A1 (en) 1994-10-05
NZ263904A (en) 1996-11-26
GR3024788T3 (en) 1998-01-30
FI113539B (fi) 2004-05-14
EP0701562B1 (en) 1997-06-18
ATE154605T1 (de) 1997-07-15
NO953878L (no) 1995-12-01
CA2159451A1 (en) 1994-10-13
DK0701562T3 (da) 1997-07-07
NO953878D0 (no) 1995-09-29
CN1120338A (zh) 1996-04-10
HU9502854D0 (en) 1995-11-28
DE69403910T2 (de) 1998-01-29
CN1229084A (zh) 1999-09-22
DE69403910D1 (de) 1997-07-24
ZA942092B (en) 1994-10-24
IL109152A0 (en) 1994-06-24
CN1046288C (zh) 1999-11-10
JPH08508481A (ja) 1996-09-10
FI954615L (fi) 1995-09-28

Similar Documents

Publication Publication Date Title
ES2105684T3 (es) Derivados insaturados de fosfonato de purinas y pirimidinas.
ES2103966T3 (es) Uso de una timosina en el tratamiento de hepatitis c.
ES2113881T3 (es) Derivados y analogos de acido 2-desoxi-2,3-didehidro-n-acetil neuraminico y su utilizacion como agentes antivirales.
SE8801406L (sv) Medel mot retrovirala infektioner
GT199900166A (es) Compuesto quìmico adecuado para usar como agente antiviral.-
ES2192301T3 (es) Derivados de resorcinol.
ES2177695T3 (es) Uso de derivados funcionales de la molecual de adhesion intercelular icam-1 en terapia antiviral.
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
AR007997A1 (es) Un derivado de distamicina sustituida con acriloilo, sus utilizaciones, un procedimiento para producirlo y una composicion farmaceutica que lo comprende.
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
NO983090L (no) Terapeutiske forbindelser
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o
ES2103577T3 (es) Compuestos antiviricos de naftoquinona, composiciones que los contienen y utilizaciones de estos compuestos.
ATE71840T1 (de) Virushemmende nukleosidmischung.
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
MX9700414A (es) Agentes antivirales de difluoroestatona.
MX9300035A (es) Tratamiento de movimiento involuntarios con agonistas de receptores de 5ht1a.
UY26250A1 (es) Sulfonamidas sustituidas con naftilo
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
ES2088458T3 (es) Fraccion antiviral de extracto acuoso de lentinus edodes.
DK0516660T3 (da) Anvendelse af S-adenosylmethionin som middel mod virale infektioner med retrovira
BR0109345A (pt) Compostos com atividade anti-hiv

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 701562

Country of ref document: ES